EQS-News: Symrise starts successfully into fiscal year 2023
EQS-News: Symrise AG
/ Key word(s): Quarter Results
Symrise starts successfully into fiscal year 2023 (news with additional features)
26.04.2023 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Trading Statement January – March 2023 Holzminden, Germany, April 26, 2023
Symrise starts successfully into fiscal year 2023
— Sales growth of 12.8 % in reporting currency in the first quarter — Group sales rise to € 1.2 billion — Organic growth of 10.6 % — Targets for 2023 and medium-term goals for 2025 confirmed
|
Symrise AG made a successful start into the new year, benefiting from continued high demand and broad positioning. In the first quarter, the Group increased sales in the reporting currency by 12.8 % to € 1,230.2 million (Q1 2022: € 1,090.6 million). The company also recorded substantial organic sales growth of 10.6 % (previous quarter 8.3 %). Both segments contributed to the positive development. Dr. Heinz-Jürgen Bertram, CEO of Symrise AG: “Symrise was able to seamlessly continue last year's positive business development at the beginning of this year. Despite high inflation and continued volatility in our markets, we are optimistic about the rest of the year and expect robust demand. Our diversified portfolio and our broad international positioning will also help us realize our growth potential and create lasting value this year. We therefore also confirm our outlook. For the current fiscal year, we are aiming for organic sales growth of 5 % to 7 % and an EBITDA margin of around 20 %." Scent & Care: High demand for cosmetic ingredients Scent & Care, the business with fragrances, aroma molecules and cosmetic ingredients, generated sales of € 454.0 million and grew by 8.3 % compared with the previous year's quarter (Q1 2022: € 419.3 million). Sales grew organically by 4.2 %. In the Fragrance division, the luxury segment continued to show especially strong momentum. The Fine Fragrances business unit in particular benefited from this, generating growth in the high double-digit percentage range compared to the first quarter of the previous year. Sales in Consumer Fragrances achieved single-digit growth. Especially hygiene and cleaning products enjoyed great demand. In the Aroma Molecules division, the difficult market environment led to a declining sales. Increasing competitive pressure from Asia and high inventories held by customers led to lower sales volumes. The menthols and terpenes product groups suffered from lower demand versus last year. Sales in the Cosmetic Ingredients division continued to develop strongly in the first quarter of the current year, with organic growth in the double-digit percentage range. The most important growth drivers were the EAME regions (Europe, Africa, Middle East) and Latin America. Application areas with active cosmetic ingredients grew strongly. Portfolio effects from the acquisitions of the French companies Néroli and Romani contributed to the segment’s sales with a total of € 15 million. Taste, Nutrition & Health: Significant growth in applications for pet food as well as for food and beveragesThe Taste, Nutrition & Health segment, in which Symrise bundles activities relating to taste solutions for food and beverages, pet food and nutrition, increased its sales by 15.6 % to € 776.1 million (Q1 2022: € 671.3 million). Organic growth reached 14.6 %. All regions contributed to this positive result. Strong growth drivers were the Latin America and EAME regions (Europe, Africa, Middle East). The Food & Beverage division, with its beverages and sweet and savory application areas, achieved high, in some cases double-digit growth rates. Here too, the highest growth was achieved in the Latin America and EAME regions. The Pet Food division continued its high double-digit growth rates. The strongest momentum for growth came from the EAME (Europe, Africa, Middle East) and Asia/Pacific regions. Expansion of capacity in Brazil, Mexico and North America is progressing and creating the basis for further international expansion of the business. The sales contribution from the acquisition of Wing Pet Food in China was € 10 million in total. Symrise confirms growth and profitability targets Despite the current volatile market environment resulting from the war in Ukraine and persistently high inflation rates in many countries, Symrise is well-positioned to continue its profitable growth path, especially by expanding capacity and increasing prices. The company has a robust business model, a diversified portfolio of applications and a broad regional presence and customer base. Symrise confirms its long-term profitable growth course. The company continues to expect to grow faster than the relevant market and to increase sales by 5 % to 7 % annually (CAGR) until 2025, with an EBITDA margin in the range of 20 % to 23 %. Despite continued high raw material prices and high logistics and energy costs, Symrise is aiming for an EBITDA margin of around 20 % in the 2023 fiscal year. About Symrise: Symrise is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, the pharmaceutical industry and producers of nutritional supplements and pet food. Its sales of approximately € 4.6 billion in the 2022 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented in more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise – always inspiring more …www.symrise.com
2023 Financial CalendarMay 10 – Annual General Meeting August 02 – Half-yearly financial report January–June 2023 October 25 – Trading statement January–September 2023
Additional features:
File: SYM_Fact_Sheet_Q1_en
26.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
Language: |
English |
Company: |
Symrise AG |
|
Mühlenfeldstraße 1 |
|
37603 Holzminden |
|
Germany |
Phone: |
+49 (0)5531 90 0 |
E-mail: |
[email protected] |
Internet: |
www.symrise.com |
ISIN: |
DE000SYM9999, DE000SYM7787, DE000SYM7704 |
WKN: |
SYM999 |
Indices: |
DAX |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
1616923 |
|
End of News |
EQS News Service |
1616923 26.04.2023 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
2.996,29 |
3.154,03 |
3.407,85 |
3.520,45 |
3.825,69 |
4.618,48 |
4.730,19 |
EBITDA1,2 |
630,31 |
630,52 |
685,07 |
742,08 |
813,62 |
795,42 |
851,65 |
EBITDA-Marge3 |
21,04 |
19,99 |
20,10 |
21,08 |
21,27 |
17,22 |
|
EBIT1,4 |
431,59 |
433,97 |
455,35 |
487,51 |
558,96 |
503,98 |
559,36 |
EBIT-Marge5 |
14,40 |
13,76 |
13,36 |
13,85 |
14,61 |
10,91 |
11,83 |
Jahresüberschuss1 |
275,65 |
297,69 |
297,88 |
314,95 |
385,03 |
290,70 |
344,94 |
Netto-Marge6 |
9,20 |
9,44 |
8,74 |
8,95 |
10,06 |
6,29 |
7,29 |
Cashflow1,7 |
396,18 |
441,79 |
546,76 |
635,68 |
521,56 |
360,11 |
719,51 |
Ergebnis je Aktie8 |
2,06 |
2,08 |
2,12 |
2,22 |
2,70 |
2,00 |
2,44 |
Dividende8 |
0,88 |
0,90 |
0,95 |
0,97 |
1,02 |
1,10 |
0,85 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. ![](/wp-content/uploads/assets/icon/pdf_24x24.png)
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Ernst & Young
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Symrise |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
SYM999 |
112,450 |
Halten |
15.717,37 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
33,07 |
38,71 |
0,85 |
50,22 |
KBV |
KCV |
KUV |
EV/EBITDA |
4,52 |
21,84 |
3,32 |
21,59 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
1,10 |
1,10 |
0,98 |
15.05.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
25.04.2024 |
01.08.2024 |
24.10.2024 |
06.03.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
0,03% |
7,67% |
12,86% |
23,95% |
|
|